Efficacy and safety of risperidone in psychotic patients: An open study

Journal of International Medical Research

Volumn 24, Issue 3, 1996, Pages 291-295

  Daradkeh, T K ^a   Reda, F ^a   Karim, L ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Efficacy; Psychoses; Risperidone

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; NEUROLEPTIC AGENT; RISPERIDONE;

ADULT; AGGRESSION; AGITATION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MALE; MANIC DEPRESSIVE PSYCHOSIS; NEGATIVE SYNDROME; PSYCHOSIS; RATING SCALE; RESTLESSNESS; SCHIZOIDISM; SCHIZOPHRENIA;

EID: 0030014212     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/030006059602400309     Document Type: Article

References (11)

1. 2 antagonist properties. J Pharmacol Exp Ther 1988; 244: 685-693.
2. Peuskens J, on behalf of risperidone Study Group: Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Br J Psychiatry 1995; 166: 712-726.
3. Marder SR, Meibach RC: Risperidone in the treatment of schizophrenia. Am J Psychiatry 1994; 151: 1825-1835.
4. Overall JF, Gorham DR: The Brief Psychiatric Rating Scale. Psychol Rep 1962; 10: 799-812.
5. Lager AC, Kirch DG, Wyatt RJ: A negative symptom rating scale. Psychiatry Res 1985; 16: 27.
6. Guy W: ECDEU assessment manual for psychopharmacology. DHEW publication. Washington, DC: US Government Printing Office, 1976; pp. 534-537.
7. Borison RL, Pathiraja AP, Diamond BL, et al: Risperidone: clinical safety and efficacy in schizophrenia. Psychopharmacol Bull 1992; 28: 213-218.
8. Chouinard G, Jones B, Remington G, et al: A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. J Clin Psychopharmacol 1993; 13: 25-40.
9. Claus A, Bollen J, De Cuper H, et al: Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients. Acta Psychiatr Scand 1992; 85: 295-305.
10. Muller-Spahn F and the International Risperidone Research Group: Risperidone in the treatment of chronic schizophrenic patients: an international double-blind parallel-group study versus haloperidol. Clin Neuropharmacol 1992; 15(suppl 1): 90A-91A.
11. Jacobsen FM: Risperidone in the treatment of affective illness and obsessive compulsive disorder. J Clin Psychiatry 1995; 56: 423-429.